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Blocking late stages of splicing quickly limits pre-spliceosome assembly in vivo
Gonzalo I. Mendoza-Ochoaa*, J. David Barrass a, Isabella E. Maudlina‡, and Jean D. Beggs a
aWellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK
ABSTRACT
Pre-messenger RNA splicing involves multi-step assembly of the large spliceosome complexes that
catalyse the two consecutive trans-esterification reactions, resulting in intron removal. There is evidence
that proof-reading mechanisms monitor the fidelity of this complex process. Transcripts that fail these
fidelity tests are thought to be directed to degradation pathways, permitting the splicing factors to be
recycled. While studying the roles of splicing factors in vivo, in budding yeast, we performed targeted
depletion of individual proteins, and analysed the effect on co-transcriptional spliceosome assembly and
splicing efficiency. Unexpectedly, depleting factors such as Prp16 or Prp22, that are known to function at
the second catalytic step or later in the splicing pathway, resulted in a defect in the first step of splicing,
and accumulation of arrested spliceosomes. Through a kinetic analysis of newly synthesized RNA, we
observed that a second step splicing defect (the primary defect) was rapidly followed by the first step of
splicing defect. Our results show that knocking down a splicing factor can quickly lead to a recycling
defect with splicing factors sequestered in stalled complexes, thereby limiting new rounds of splicing.
We demonstrate that this ‘feed-back’ effect can be minimized by depleting the target protein more
gradually or only partially, allowing a better separation between primary and secondary effects. Our
findings indicate that splicing surveillance mechanisms may not always cope with spliceosome assembly
defects, and suggest that work involving knock-down of splicing factors or components of other large
complexes should be carefully monitored to avoid potentially misleading conclusions.
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Pre-messenger RNA (pre-mRNA) splicing is the process by which
introns are removed from RNA transcripts and the coding
sequences are joined by two consecutive trans-esterification reac-
tions catalysed by the spliceosome (reviewed in [1–3]). The spli-
ceosome is a multi-megadalton RNA-protein complex that is
assembled from five small nuclear ribonuclear protein particles
(snRNPs) (U1, U2, U4, U5 and U6 snRNPs) plus non-snRNP
proteins, including the nineteen complex (NTC) andNTC-related
proteins. Spliceosome assembly is a highly dynamic process (Fig.
1a). Briefly, U1 andU2 snRNPs recognize and bind at the intron 5ʹ
splice site (5’ss) and branch site (BS), respectively, to form the pre-
spliceosome, or A complex. Association of the U4/U6.U5 triple
snRNP produces a transient pre-B complex from which the U1
snRNP is displaced to produce the more stable B complex, then
removal of the U4 snRNP and recruitment of NTC forms the Bact
complex, followed by a further reorganization to create the cata-
lytically active B* complex. The first catalytic step of splicing takes
place, and the resulting C complex is remodelled again (C* com-
plex), leading to the second catalytic step. Finally, the post-catalytic
spliceosome is actively disassembled and the components are
recycled.
Thanks to extensive biochemical and genetic studies
(reviewed in [4]), together with high-resolution structures
obtained by cryo-electron microscopy [5–13], we now have
a comprehensive mechanistic understanding of splicing.
However, until relatively recently, pre-mRNA splicing was
studied mainly as an isolated process whereas, within the
context of the cell, splicing functionally interacts with other
cellular systems such as transcription, chromatin and RNA
processing (reviewed in [14]).
Most splicing factors are essential for viability. Therefore,
in vivo studies of the roles of pre-mRNA splicing factors have
generally involved the use of conditional mutants (in yeast) or
targeted knock-down of individual factors (e.g. by RNAi in
higher eukaryotes). In this study, we were particularly interested
in Prp16 and Prp22, which are members of the family of DEAH-
box RNA-stimulated ATPases, or RNA helicases, that promote
structural rearrangements in splicing complexes (reviewed in
[15]). Prp16 binds at, or near, the 3’ss, and triggers the formation
of C complex and activation of the catalytic core [5,6,16],
whereas Prp22 sits downstream of the 3’ss and releases the
spliced mRNA from the post-spliceosome [5,17–19]. Prp22 has
also been implicated in the second catalytic step of splicing [20]
and in 3’ss selection [21,22].
Our goal was to study the effects on splicing efficiency and co-
transcriptional spliceosome assembly of knocking down Prp16
or Prp22 in vivo. For comparison, we studied two other splicing
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factors, tri-snRNP protein Prp4 and NTC-related protein Prp45,
that are involved in different stages of spliceosome assembly. To
achieve a fast and specific depletion of our target proteins we
used the auxin-inducible degron system [23,24].
Although surveillance mechanisms have the ability to iden-
tify defective splicing complexes and target them for dissocia-
tion and recycling of the components, our results show that
rapid depletion of a splicing factor in vivo can limit the early
steps of spliceosome assembly, indicating that the recycling
process is overwhelmed. Consequently, the observed pheno-
types do not reflect the primary function of the depleted
factor. In the case of Prp22, we demonstrate that a more
gradual and less complete depletion strategy allows for separa-
tion of the primary and secondary effects. We conclude that
the budding yeast surveillance and recycling processes cannot
cope with large-scale inhibition of splicing, highlighting the
need for caution in interpreting the results of in vivo knock-
down studies to analyse the roles of different components of
a biochemical pathway.
Methods
Yeast strains and growth conditions
See Table S1 for yeast strain genotypes. The OsTIR1 auxin-
binding protein was expressed in S. cerevisiae strains PADH1-
701-TIR1 or PADH1-409-TIR1 (depletes more gradually than
PADH-701) directed by constitutive PADH1 promoters, whereas
in PZ4EV-NTIR1 it is subject to regulated expression from a β-
estradiol-inducible promoter [25] as previously described [23].
Target proteins were C-terminally tagged with AID*-6FLAG
(referred to in the text simply as ‘AID-tagged’) [26], using
a b
c d
Figure 1. Depletion of splicing factors Prp4, Prp22, Prp16 or Prp45 leads to a first step of splicing defect. (a) Spliceosome assembly model showing recruitment of U1,
U2, U4, U5 and U6 snRNPs, nineteen complex (NTC) and splicing factors that were depleted in this study, and their critical stage of activity. (b) Auxin-dependent
targeted depletion assessed by immunoblotting with anti-FLAG and anti-Pgk1 (internal control) antibodies. Prp4 was depleted in strain PADH1-409-TIR1. Prp16,
Prp22 and Prp45 were depleted in strain PADH1-701-TIR1. Target protein levels after depletion (+ auxin) are shown in green numbers as a percentage of the starting
amount, and represent the average of three biological replicates. The anti-FLAG signal was normalized against Pgk1, which is encoded by an intronless gene and was
used as internal control. Only one representative blot is shown. (c) Illustration of qPCR-amplified regions from ACT1 and ECM33 transcript: 5ʹ splice site (5’ss) (ECM33
only), Branchsite (BS) (ACT1 only), 3ʹ splice site (3’ss), exon 2, lariat and spliced mRNA. 5’ss and BS primers only detect pre-mRNAs, 3’ss primers will detect pre-mRNA
and also lariat-exon2, a product of the first step of splicing. Lariat will detect both the lariat-exon2 and excised lariat (a product of the second step of splicing). mRNA
is produced in the second step of splicing. Exon primers are used as controls to normalize for transcription. (d) qPCR of splicing intermediates of ACT1 at 30 min
depletion, normalized to exon 2 and relative to no depletion (time 0). Pre-mRNA accumulation (increase 3´ss and BS) is indicative of a first step of splicing defect.
Error bars denote standard error of biological triplicates. † a second step function of Prp22 may not be required for splicing of all intron-containing transcripts[20].
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a PCR-basedmethod to alter the coding sequence on the genome
[27]. Prp16, Prp22 and Prp45 were individually depleted in
PADH1-701-TIR1 while Prp4 was depleted in PADH1-409-
TIR1 (Figs. 1–3). Depletion of Prp16 in Fig. 4c was done in
strain PZ4EV-NTIR1. Where specified, more gradual depletion
of Prp22 (Fig. 5) was performed in strain PADH1-409-TIR1.
Yeast strains were grown at 30°C on Yeast Peptone Dextrose
supplemented with adenine (YPDA). Protein depletions were
performed as previously described [23].
Antibodies used
Western blots were performed as previously described [23],
using rat anti-FLAG (Agilent, Cat. No. 200474) and mouse
anti-PGK1 (Abcam, Cat. No. Ab113687) antibodies. The anti-
FLAG signal was normalized against Pgk1, which is encoded
by an intronless gene and was used as internal control. Rabbit
anti-Prp40 polyclonal antibodies (our laboratory) were used
for ChIP of U1 snRNP, and mouse anti-HA 12CA5 mono-
clonal antibodies (Roche, Cat. No. 11583816001) were used
for ChIP and RIP of U2 snRNP.
RNA analysis and chromatin immunoprecipitation
Reverse transcription (RT) was performed as previously
described [28]. 2x SYBR green III master mix (Agilent Cat.
600882-51) was used for quantitative polymerase chain reac-
tion (qPCR). Oligonucleotide primers for RT and qPCR are
listed in Supplemental Methods. RNA immunoprecipitation
(RIP) was performed as previously described [29]. Protocol
for chromatin immunoprecipitation-quantitative PCR (ChIP-
qPCR) is described in Supplemental Methods. Isolation of
total RNA and newly synthesized RNA (nsRNA) by 4-thio-
uracil (4tU) labelling were performed as described previously
[30] with a few modifications [31].
Results
Depletion of Prp16 or Prp22 causes a first step of splicing
defect
We investigated the effect on splicing efficiency in vivo of
depleting Prp4, Prp16, Prp22 or Prp45. For this we individu-
ally C-terminally tagged these proteins with the AID*-6FLAG
tag [26] in Saccharomyces cerevisiae strains that constitutively
express the plant auxin-binding receptor TIR1. We added
auxin to cultures of the AID-tagged strains and took samples
for analysis immediately (T0) and after 30-min incubation
(T30). By western blot analysis, we estimated that Prp4 was
depleted to around 20%, and Prp45, Prp16 and Prp22 were
depleted to less than 7% of initial values (Fig. 1b). Having
confirmed that targeted depletion was successful, we mea-
sured the relative abundance of the pre-mRNA, the lariat-
exon2 splicing intermediate and spliced mRNA of ACT1
transcripts by reverse transcriptase real-time quantitative
PCR (RT-qPCR) using specific primers (Fig. 1c,d). As antici-
pated, depletion of tri-snRNP protein Prp4 or NTC-related
Prp45 (proteins recruited before the first step of splicing) led
to an increase in signal across both the branchsite (BS),
representing unspliced pre-mRNA; and 3ʹ splice site (3’ss),
due to unspliced pre-mRNA or lariat-exon2 levels, while lariat
levels decreased due to reduced production of lariat-exon2
and/or excised intron. These observations indicate a defect
in the first step of splicing. Depletion of Prp16 or Prp22 led to
increased lariat and 3’ss signals, indicative of a second step
defect but, unexpectedly, also to increased BS levels, suggest-
ing that both steps of splicing were negatively affected by
reduction in these late-acting splicing factors. Because it is
unlikely that both Prp16 and Prp22 have an additional and
uncharacterized role in the first catalytic step of splicing, we
speculated that the observed phenotype was an indirect con-
sequence of depleting these proteins.
Pre-spliceosome formation is reduced in the absence of
Prp4, Prp45, Prp16 or Prp22
It was previously demonstrated that the co-transcriptional
recruitment of splicing factors can be monitored in vivo
using the chromatin immunoprecipitation (ChIP) approach,
because splicing factors bound to nascent transcripts are suf-
ficiently close to RNA polymerase to interact, either directly
or indirectly, with the DNA template [29,32–36]. Therefore,
to study the effect on early stages of co-transcriptional spli-
ceosome assembly of depleting Prp16 or Prp22, we performed
ChIP of Prp40 and HA-tagged Lea1, as core components of
U1 and U2 snRNP, respectively, at the well characterized
intron-containing ACT1 and ECM33 genes. In the undepleted
controls, we observe the typical profiles for ChIP of U1 and
U2 snRNP components, with both signals high over exon 2
but U1 snRNP signal declining more 5ʹ than the U2 signal,
representing release of the U1 snRNP as B complex forms
(Fig. 2) [33,34]. Following depletion of Prp4, we observe lower
occupancy of Prp40 (U1) and Lea1 (U2), compared to the
undepleted control. Given that Prp4 joins after pre-
spliceosome formation (Fig. 1a), these data suggest that
depleting Prp4 also causes an unexpected defect in U1 and
U2 snRNP recruitment. In the absence of Prp45, we observe
lower occupancy of Lea1 (U2), and higher occupancy of
Prp40 (U1) towards the 3ʹ end of the genes (Fig. 2), indicating
reduced and possibly delayed U2 recruitment, which agrees
with our previous observation of Prp45 depletion causing a
first step of splicing defect. The elevated U1 signal is likely
caused by failure to form B complex, which normally involves
U1 release [37]. In the absence of either Prp16 or Prp22, we
again observe lower occupancy of Lea1 (U2) and higher
occupancy of Prp40 (U1), similar to depletion of Prp45.
Given that each of these four factors is thought to function
after U1 and U2 snRNP recruitment, the reduced ChIP signal
for U2 snRNP suggests that depleting any one of these pro-
teins also causes a defect at an earlier than expected stage of
spliceosome assembly.
To explain these unusual observations, we hypothesize that
depletion of any of these four splicing factors causes accumu-
lation of arrested complexes, with splicing components
becoming sequestered, which leads to reduced spliceosome
assembly on newly synthesized transcripts and a first step
splicing defect.
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Depletion of splicing factors correlates with increased
snRNP interactions
To test the hypothesis that splicing complexes accumulate in
cells depleted of these splicing factors, we performed an RNA
immunoprecipitation (RIP) analysis where HA-tagged Lea1
(U2) was pulled down and the associated snRNAs were mea-
sured by RT-qPCR. The normal pattern of Lea1 (U2 snRNP)
association with U1, U4, U5 and U6 snRNAs is presented in
Fig. 3a. Prp4 is required for tri-snRNP recruitment, a step
necessary for the transition of pre-spliceosome to pre-B com-
plex (Fig. 1a) [38]. Therefore, based on the ChIP data we
anticipate that absence of this protein may lead to the accu-
mulation of pre-spliceosome complexes (U1 and U2 snRNPs).
Indeed, we observe that depletion of Prp4 correlates with
increased association of Lea1 with U1 snRNA, and decreased
association with U4, U5 and U6 snRNAs, relative to the
undepleted control (Fig. 3b).
In the case of Prp45 depletion, the slightly elevated asso-
ciation of Lea1 with U1 and U4 compared with the unde-
pleted control may indicate accumulation of pre-B and/or
B complex, as a result of inefficient conversion of B complex
to Bact complex (Fig. 3b). Prp45 is an NTC-related protein,
and it has been proposed that the NTC functions at the
transition from B to Bact complex by stabilizing the associa-
tion of the U5 and U6 snRNAs with the 5ʹ end of the intron
after U4 is dissociated [39]. In view of the slightly reduced
association of Lea1 with U5, ChIP was performed for the U5
snRNP protein, Prp8, showing that co-transcriptional recruit-
ment of U5 snRNP was also reduced following depletion of
Prp45 (Fig S1), adding further support for failure to form
a stable B complex.
In contrast, depletion of Prp16 or Prp22, correlates with
increased association of Lea1 with U5 and U6 snRNAs, suggest-
ing accumulation of Bact and/or C complexes that contain U2,
Figure 2. Depletion of several splicing factors (as in Fig. 1) leads to reduced co-transcriptional recruitment of Lea1 (U2 snRNP). ChIP of Prp40 (U1 snRNP; black lines)
and HA-tagged Lea1 (U2 snRNP; red lines) on ACT1 (left plots) and ECM33 (right plots) genes before (solid lines) and after (dashed lines) auxin-induced depletion. The
x-axis represents amplicon location within the gene. For each protein, the ChIP data are presented as relative to the first amplicon for that protein – in the exon 1 of
ACT1 and 5ʹUTR of ECM33. Error bars denote standard error of biological triplicates. U1 and U2 ChIP values following Prp45 depletion are at different scales (y-axis
values of U1 ChIP are shown on the left of the graph and U2 ChIP values on the right) due to experimental variations (e.g. variations in immunoprecipitation
efficiencies). * = AID*-6FLAG C-terminus tag.
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U6 and U5 snRNAs. In the case of Prp16 depletion, there is also
decreased association with U1 and U4 snRNAs (Fig. 3b), possi-
bly indicating reduced pre-spliceosome and/or B complex for-
mation. These observations resemble reports of arrested
spliceosome accumulation in temperature-sensitive prp2, prp16
and prp22mutant strains [40]. As the ChIP results show reduced
co-transcriptional recruitment of U2 snRNP (and likely also of
U5 and U4/U6 snRNPs, whose assembly requires pre-
spliceosome formation), we conclude that the RIP data reflect
the post-transcriptional accumulation of stalled spliceosomes.
This can explain both the reduced U2 recruitment to newly
synthesized transcripts (Fig. 2) and pre-mRNA accumulation
(Fig. 1d).
Kinetic analysis of Prp22 and Prp16 depletion
Next, we studied the kinetics of the splicing defect caused by
Prp22 depletion by analysing both 4-thiouracil (4tU)-labelled
nascent RNA [30] and co-transcriptional recruitment of Lea1
(U2 snRNP) at short times (0, 3, 6 and 12 min) after auxin
addition. Labelling RNA with 4tU in vivo for as little as 1 min
allows the isolation of newly synthesized RNA (nsRNA), and
its production and processing can be assessed as the protein is
depleted, whereas total RNA (Fig. 1) includes RNA produced
prior to target protein depletion. The 4tU splicing analysis
shows ACT1 lariat abundance elevated compared to the signal
from exon 2 in the sample incubated with auxin for 3 min,
then decreasing (relative to exon 2), as the BS (pre-mRNA)
signal builds up (Fig. 4a). Moreover, the 3’ss signal also
accumulates transiently in parallel with the lariat signal, levels
off as lariat declines and BS increases, then accumulates again
in parallel with the BS signal. These results indicate that the
lariat-exon2 product of the first step of splicing accumulates
transiently before a first step defect kicks in and prevents
further lariat-exon2 production.
Consistently, the ChIP signal for Lea1 (U2 snRNP) at
ACT1, is reduced in the 6-min sample but not in the 3-min
sample (Fig. 4b), indicating reduced recruitment of U2 snRNP
to nascent RNA after only 6 min of Prp22 depletion. This can
explain the first step defect detected at 6 min as being due to
reduced co-transcriptional spliceosome assembly. Taken
together, the kinetic analyses indicate that although the first
step splicing defect occurs extremely rapidly after auxin addi-
tion, it is preceded by a second step defect, arguing that the
first step splicing defect is not a direct consequence of Prp22
depletion, but a secondary effect. In the case of ECM33
transcript, we observe 5’ss (pre-mRNA) signal increase at 6
min, and also reduced recruitment of U2 snRNP (Lea1)
already at 3 min (Fig. 4a, B; specific assay of ECM33 lariat
by RT-qPCR has not been achieved).
We performed a similar kinetic analysis of Prp16 depletion,
this time using a Prp16 AID-tagged strain in which TIR1 is
conditionally expressed by the addition of β-estradiol prior to
auxin addition, permitting tighter control of the system [23].
The results were similar to those for Prp22 depletion, with
lariat signal peaking at 6 min after auxin addition, then
decreasing as the BS signal increased but, notably, after
a significant lag (Fig. 4c).
A more gradual depletion of Prp22 increases contrast
between primary and secondary effects
As depletion of Prp22 in the PADH1-701-TIR1 strain affected
splicing extremely quickly, and from a situation where this
protein was already partially depleted without auxin, we ana-
lysed another AID strain, PADH1-409-TIR1, that expresses
TIR1 at a lower level and, therefore, allows a more gradual
depletion of Prp22 and from a starting point of no auxin-
independent depletion [23]. Analysis of total RNA (Fig. 5a)
showed that reduction of Prp22 to 42% of the initial level took
15 min as opposed to 3 min with the more rapidly depleting
strain (shown in Fig. 4b), and caused only a low level of lariat
accumulation. At 30 min, when Prp22 was reduced to 20%,
there was accumulation of more lariat, as well some 3’ss signal
and, to a lesser extent, BS signal, indicating a small amount of
pre-mRNA. At 60 min, with only 9% Prp22 remaining, the
signals for lariat, 3’ss and BS were all strongly elevated.
4tU-labelling analysis of the kinetics of splicing with gradu-
ally depleted Prp22 (Fig. 5b) also showed that 15 min after auxin
addition, with 42% of Prp22 remaining, there was significant
accumulation of only the lariat signal, indicative of excised
intron lariat accumulation. At 30 min (Prp22 at 20%) 3’ss signal
remained low, whereas at 60 min (Prp22 at 9%) the 3’ss signal
accumulated at a similar rate to lariat signal, and there was very
little BS (pre-mRNA) accumulation, indicating build-up of lar-
iat-exon2. In summary, during a more gradual Prp22 depletion,
excised intron lariat clearly accumulated before the lariat-exon2
product of the first step, and there was little pre-mRNA
a
b
Figure 3. Level of association of U2 snRNP with U1, U4, U5 and U6 snRNAs is
altered in the absence of certain splicing factors. (a) RT-qPCR measurement of
snRNAs associated with immunoprecipitated, HA-tagged Lea1, a core compo-
nent of U2 snRNP. (b) RNA immunoprecipitation (RIP) analysis as in panel a after
depletion of Prp4, Prp45, Prp16 or Prp22 as in Fig.1. Data are normalized to U2
snRNA signal and presented as relative to no depletion (time 0). Error bars
denote standard error of biological triplicates. * = AID*-6FLAG C-terminal tag.
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accumulation, indicating that, under these milder depletion
conditions, the first step of splicing was hardly affected.
Discussion
Our observation of pre-mRNA accumulation when depleting
Prp16 or Prp22 resembles previous studies showing pre-
mRNA accumulation at the restrictive temperature in strains
with heat-sensitivemutants of PRP16 [41,42] and PRP22 [17,41–
43]. A homozygous lethal mutation of the zebrafish orthologue
of Prp22 (called Dhx8), also caused accumulation of unspliced
pre-mRNA [44], indicating that this phenotype is not specific to
yeast. Company et al. [43]speculated that in a heat-sensitive
prp22 strain unspliced pre-mRNA accumulated because defec-
tive spliceosomes were not recycled for new rounds of splicing,
but this was not investigated further. Evidence supporting the
concept of defective spliceosomes limiting an earlier step came
subsequently, in a report that metabolic depletion of U5 snRNA
caused accumulation of arrested pre-spliceosomes and reduced
co-transcriptional recruitment of U1 and U2 snRNPs [29],
which is similar to our Prp4 depletion analysis. However, as
the GAL promoter-driven expression of U5 snRNA was
repressed for 16 h, it cannot be ruled out that the recycling defect
was an indirect consequence of the prolonged splicing defect.
For example, reduced expression of intron-containing genes that
encode splicing factors (e.g. U1 snRNP protein Mud1) could
explain the reduced co-transcriptional recruitment of U1 snRNP
that was observed.
Our AID depletion approach is novel because (1) we target
not just one, but different stages of splicing, (2) we deplete the
target proteins very rapidly, (3) we analyse both the efficiency of
splicing newly synthesized transcripts and co-transcriptional
snRNP recruitment, and (4) we demonstrate the accumulation
of different splicing complexes depending on the stage at which
the depleted factor functions. Taken together, data derived from
this approach and from previous studies [29,40] demonstrate
that perturbing splicing can lead to a recycling defect that limits




Figure 4. Kinetic analysis of newly synthesized RNA after depletion of Prp22 or Prp16. (a) RT-qPCR analysis of 4tU-labelled newly synthesized RNA of ACT1 and
ECM33. Following Prp22 depletion (in strain PADH1-701-TIR1) for the times indicated, samples were 4tU-labelled for 1 min. Data are normalized to conditions without
depletion. (b) Occupancy of U2 snRNP-core component Lea1 was measured from depletion time course samples as in panel a. Solid red lines are Lea1 ChIP-qPCR for
ACT1 and ECM33, and dashed black lines are Prp22 levels measured by western blot (blot image not shown). ChIP data are normalized against background (intron-
less ALG9). Prp22 western blot signal is normalized against internal control Pgk1. (c) RT-qPCR analysis of 4tU-labelled (1-min labelling) newly synthesized ACT1 RNA,
following Prp16 depletion in strain PZ4EV-NTIR1, with osTIR1 expression induced by β-estradiol[23]. Relative levels (%) of Prp16 protein are in X-axis below minutes.
Data in panels (a) and (c) are normalized against exon 2. Data in all panels (a-c) are relative to no depletion (time 0) and x-axes represent time (minutes) after
addition of auxin. Error bars denote standard error of four (panels a-b) or three (panel c) biological replicates.
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back’ effect happens extremely rapidly, suggesting that spliceo-
some disassembly can become a rate-limiting step for splicing,
and supporting the proposal that pre-mRNA substrates compete
for a limited pool of spliceosome components in yeast [45].
Moreover, we demonstrate that the effect is indeed titratable;
partial and/or slower depletion of Prp22 resulted in a less severe
defect, allowing the kinetics of this effect to be analysed.
Therefore, we propose that by controlling the rate and optimiz-
ing the extent of depletion, one can minimize secondary effects
associated with recycling defects and thereby facilitate the func-
tional analysis of a targeted protein.
Similar to our results for Prp45 depletion, Hálová et al.
[46] also observed a reduction in co-transcriptional U2
snRNP recruitment when they analysed the effect of truncat-
ing the C-terminal domain of Prp45, proposing that Prp45
has an earlier than expected role in splicing, at the stage of U2
snRNP recruitment. Our observation that Prp45 depletion
leads to enhanced U1 snRNP and reduced U2 snRNP signal
at the site of transcription could support either a role for
Prp45 in U2 snRNP recruitment or, alternatively, may indi-
cate a recycling defect. Prp45 depletion also resulted in
a mildly increased association of U2 with U1 and U4 (our
RIP analysis), possibly indicating pre-B and/or B complex
accumulation (Fig. 3b). This seems plausible, as Prp45 is an
NTC-related protein, and it has been proposed that the NTC
functions at the transition from B to Bact complex by stabiliz-
ing the association of the U5 and U6 snRNAs with the 5ʹ end
of the intron after U4 is dissociated [39]. Prp45 has an
extended conformation in the spliceosome [12], interacting
with many spliceosome components. It is conceivable that
depletion of Prp45 could directly affect more than one step
in the splicing cycle, perhaps even in a substrate-specific
manner, which could make mutation or depletion results
difficult to interpret.
Chen et al. [47] tested the ability of the NTR disassembly
complex (containing Prp43, Ntr1 and Ntr2) to mediate sub-
strate release from the spliceosome when various DEAH-box
RNA-stimulated ATPases were mutated or immunodepleted
in vitro. They concluded that only spliceosome intermediate
complexes that were arrested after, but not before, the ATP-
dependent action of Prp2, Prp16 or Prp22 could be actively
disassembled. Our in vivo analyses of Prp16 and Prp22 deple-
tion are also consistent with failure to disassemble complexes
stalled before these proteins act. Furthermore, our analyses
show that recycling defects are not limited to knockdown of
RNA-stimulated ATPases, as depletion of Prp4 or Prp3,
another tri-snRNP protein, displayed similar defects (Fig. S2).
The DEAD/H-box RNA-stimulated ATPases were pro-
posed to function as proofreading or fidelity factors in spli-
cing based on assays using reporter genes encoding aberrant
or suboptimal pre-mRNA substrates (e.g. pre-mRNAs with
non-canonical splice sites or branchsites) [48,49]. It was
further proposed that defective complexes are removed by
a discard pathway [50,51]. In this work, we focused on
a different type of aberrant spliceosomes – those that contain
normal pre-mRNA substrates but defective splicing machin-
ery. This situation leads to a wide-spread defect, that may
overwhelm surveillance pathways, such that the splicing fac-
tors become sequestered in defective complexes, limiting the
assembly of new spliceosomes. Interestingly, in the strain
where Prp22 was more gradually depleted, accumulation of
pre-mRNA (Branchsite) was both slower than lariat accumu-
lation in the same conditions (Fig. 5a) and reduced compared
to fast depletion of Prp22 (Fig. 1d), suggesting that a recycling
defect is more likely when the target is rapidly depleted, and/
or knocked down to low levels. Considering all evidence, it
seems that the splicing surveillance machinery likely has the
capability to recognize aberrant spliceosomes that either lack
an essential splicing factor or contain a mutant protein. This
notion is supported by evidence that mutations in disassembly
factors Spp382 (Ntr1) and Prp43 suppress the defects caused
by the spliceosome assembly mutations prp38-1 and prp8-1,
presumably by reducing dissociation of the defective com-
plexes, thereby allowing more time for the defective splicing
factors to function [52]. However, our results suggest that the
splicing surveillance and/or discard machinery is not
equipped to deal with a large or rapid accumulation of aber-
rant spliceosomes. We propose that when the splicing defect
is highly penetrant, the surveillance capacity of the cell can be
overwhelmed, leading to the build-up of arrested complexes.
We speculate that this might also help to explain why some
a
b
Figure 5. RNA Analysis in a time course of a more gradual Prp22 depletion.
Prp22 was depleted in strain PADH1-409-TIR1, in which OsTIR1 is expressed
to low levels[23] so the Prp22 level declines neither as far nor as fast as in
the other figures. Splicing intermediates of ACT1 were analysed by RT-qPCR
from total RNA (a) and 4tU-labelled (labelled for 4 min at each time of
depletion) newly synthesized RNA (b). Data are normalized to exon 2 and
relative to no depletion (time 0). Relative levels (%) of Prp16 protein are in
X-axis below minutes. Error bars denote standard error of biological
triplicates.
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disease-causing splicing factor alleles in humans are more
penetrant than others.
Our observed rapid accumulation of excised lariat
upon Prp22 depletion (Fig. 5) is consistent with Prp22’s
role in releasing spliced mRNA from the post-spliceosome
[17–19], a step that ultimately leads to spliceosome dis-
assembly by the NTR complex and recycling of the com-
ponents. The high level of lariat and 3’ss signals but low
level of branchsite signal for ACT1 transcripts (indicative
of a second step of splicing defect) after 3 min of rapid
depletion (Fig. 4a) or 60 min of gradual depletion (Fig.
5b) of Prp22 in the 4tU-labelling analyses supports Prp22
having an additional role in the second catalytic step of
splicing [20]. However, as excised lariat accumulated
prior to lariat-exon2 (Fig. 5) it suggests that, in vivo,
Prp22’s role in the second step of splicing is secondary
to its role in mRNA release. An alternative explanation
could be that accumulation of post-splicing complex fol-
lowing Prp22 depletion reduces the availability of second
step factors such as Prp18 and Slu7 to below a limiting
amount, thereby affecting the second step indirectly. Both
Schwer & Gross [20] and our analyses of Prp22’s role in
splicing were conducted only on ACT1 transcripts.
Therefore, it remains an open question whether this pro-
tein is also required for the second step of splicing of
other transcripts.
Different intron-containing transcripts may be more or
less sensitive to the depletion of different factors, and
splicing may be affected at different stages. It is not
always possible to distinguish first and second step spli-
cing defects by RT-qPCR, as distinguishing unspliced pre-
mRNA and lariat-exon2 intermediate species (as we have
done for ACT1) generally depends on the specific mea-
surement of lariats, which can be problematic. However,
techniques have been developed to simultaneously
sequence lariats of potentially all intron-containing tran-
scripts of S. cerevisiae [53–55]. In principle, these tran-
scriptome-wide approaches could be used to investigate,
for example, whether Prp22 is required in vivo for
the second step of splicing of only a subset of introns as
has been proposed [20].
Our observations highlight a concern that, in order to
avoid misleading conclusions when knocking down com-
ponents of large complexes, it is important to consider
possible indirect effects that can occur as a consequence
of the accumulation of a disabled complex. This is
a particular concern if the complex assembles and/or
functions in a step-wise manner, such as the spliceosome
or the ribosome assembly pathway. Ways of controlling
for this include performing kinetic analyses of the effects,
comparing the effects of depleting the target factor to
different extents and at different rates, or of depleting
different components of the complex. Therefore, when
interpreting the results of large scale knock-down studies,
for example, RNAi depletion analyses of human splicing
factors [56–58], the possibility of confounding secondary
effects should be considered.
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